Indianapolis, IN, April 18, 2011 — Acurian, Inc., a leading, full-service provider of global patient recruitment and retention solutions, was selected by Eli Lilly and Company for their 2010 Lilly Global Supplier Award. The award was presented to Acurian executives in a ceremony at the company’s headquarters in Indianapolis on April 12.
The Lilly Global Supplier Award recognizes suppliers who have worked collaboratively to deliver a positive and measurable impact on Lilly’s corporate objectives and priorities. The annual award is given to suppliers who exemplify the delivery of quality, service, speed, total cost reduction, and value.
“We are deeply honored and proud to receive this award from our valued customer,” said Acurian CEO Rick Malcolm. “This award recognizes our company’s outstanding and talented employees who consistently strive to make Acurian the global standard in efficiency, predictability, and performance.”
Acurian is a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. The company increases the enrollment performance of investigator sites worldwide by identifying, contacting, prescreening, and referring people who live in the local community but are unknown to a research site. As a result, trial sponsors complete enrollment without incurring the unexpected expense of adding sites, time, or CRO change orders. Acurian’s investors include Euclid SR Partners, ProQuest Investments, JP Morgan Partners, Flatiron Partners, CDP Capital Technology Ventures, and Merck Capital Ventures.
Scott Connor, vice president, marketing